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Abstract
Purpose—The mechanisms driving the physical activity–breast cancer association are unclear.
Exercise both increases reactive oxygen species production, which may transform normal
epithelium to a malignant phenotype, and enhances antioxidant capacity, which could protect
against subsequent oxidative insult. Given the paradoxical effects of physical activity, the
oxidative stress pathway is of interest. Genetic variation in CAT or antioxidant-related
polymorphisms may mediate the physical activity–breast cancer association.
Methods—We investigated the main and joint effects of three previously unreported
polymorphisms in CAT on breast cancer risk. We also estimated interactions between recreational
physical activity (RPA) and 13 polymorphisms in oxidative stress-related genes. Data were from
the Long Island Breast Cancer Study Project, with interview and biomarker data available on
1,053 cases and 1,102 controls.
Results—Women with ≥1 variant allele in CAT rs4756146 had a 23 % reduced risk of
postmenopausal breast cancer compared with women with the common TT genotype (OR = 0.77;
95 % CI = 0.59–0.99). We observed two statistical interactions between RPA and genes in the
anti-oxidant pathway (p = 0.043 and 0.006 for CAT and GSTP1, respectively). Highly active
women harboring variant alleles in CAT rs1001179 were at increased risk of breast cancer
compared with women with the common CC genotype (OR = 1.61; 95 % CI, 1.06–2.45). Risk
reductions were observed among moderately active women carrying variant alleles in GSTP1
compared with women homozygous for the major allele (OR = 0.56; 95 % CI, 0.38–0.84).
Conclusions—Breast cancer risk may be jointly influenced by RPA and genes involved in the
antioxidant pathway, but our findings require confirmation.
Keywords
Breast cancer; Epidemiology; Catalase; Physical activity; Oxidative stress
Introduction
Oxidative stress is hypothesized to play an important role in breast carcinogenesis [1–4] and
is caused by the imbalance of reactive oxygen species (ROS) production and antioxidant
defenses which neutralize these molecules [5]. ROS may be generated through any number
of endogenous or exogenous mechanisms. While modest levels of ROS are useful for cell
signaling processes [6], excess production may result in DNA damage, lipid peroxidation,
and protein modification [7–9]. When endogenous or exogenous ROS production occurs in
an environment with sufficient in vivo defense mechanisms to scavenge the ROS, there are
seemingly few harmful effects. When there is excess ROS production and/or insufficient
defense mechanisms, oxidative stress may ensue. There are several antioxidant defenses that
can protect against oxidative damage including catalase (CAT), manganese superoxide
dismutase (MnSOD), glutathione peroxidase (GPX), glutathione S-transferases (GSTs),
myeloperoxidase (MPO), and catechol-O-methyltransferase (COMT) [1]. CAT plays an
important role in neutralizing ROS by converting H2O2 into H2O and O2 [1]. Activity levels
of the CAT enzyme are likely affected by a functional polymorphism (rs1001179) in the
promoter region of the gene [10]. While this polymorphism has been associated with
decreased enzyme activity [11–14], its association with breast cancer risk is unclear [11, 15,
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16]. Other polymorphisms in CAT may be important in understanding the underlying
association with breast cancer incidence and should be considered.
While physical inactivity is a well-established risk factor for breast cancer [17], the
mechanisms driving the association are not well described [18–20]. Given the biological
adaptation of enhanced antioxidant enzymatic capacity that occurs with regular exercise and
its contribution to ROS, the oxidative stress pathway may be of interest. Physical activity
may therefore interact with antioxidant-related genetic polymorphisms to influence breast
carcinogenesis. No previous epidemiologic investigations have explored this possibility. We
hypothesized that genotypes related to reduced antioxidant expression may have an
antagonistic effect on the benefits of physical activity. In this report, we aimed to: (1)
examine the independent main effects of three variants in the CAT gene (rs4756146,
rs2284365, and rs480575) on breast cancer risk; (2) examine two-way interactions between
SNPs in the CAT gene and breast cancer risk; and (3) examine potential interaction between
recreational physical activity (RPA) and several oxidative stress-related genes (CAT,
COMT, GPX, GSTA1, GSTM1, GSTP1, GSTT1, MnSOD, and MPO) with respect to breast
cancer incidence. Secondary aims were to evaluate associations between CAT
polymorphisms and breast cancer with cases categorized according to tumor hormone
receptor status. These aims were accomplished through the use of existing biomarker and
questionnaire data from the Long Island Breast Cancer Study Project (LIBCSP).
Materials and methods
Study population
Study participants were from the LIBCSP, a population-based case–control study conducted
among English-speaking female residents of Nassau and Suffolk counties, Long Island, New
York. Details of the study methods have been described previously [21]. Briefly, LIBCSP
cases were women aged 20–98 years diagnosed with a first primary in situ or invasive breast
cancer between 1 August 1996 and 31 July 1997. Case women were identified through daily
or weekly contact with local hospital pathology departments. Population-based controls
were women without a personal history of breast cancer randomly selected using random
digit dialing for those under age 65 and the Health Care Finance Administration rosters for
women aged 65 and older. Controls were frequency-matched to the expected age
distribution of case women by 5-year age groups. All data were collected through a 2-h,
interviewer-administered, structured questionnaire. Interview response among eligible cases
and controls were 82.1 % (n = 1,508) and 62.8 % (n = 1,556), respectively. Respondents
were more likely to be older (median age = 57 years in cases and 56 years in controls), post-
menopausal (n = 1,003 cases and 989 controls), and white (93.4 % white, which reflects the
underlying distribution of the source population).
Of those who completed an interview, 73.1 % of cases and 73.3 % of controls donated a
blood sample. Among women who donated blood, genotyping was unavailable for 4.4 % of
cases and 3.4 % of controls primarily due to insufficient DNA. Our final sample therefore
includes 1,053 cases and 1,102 controls. Written informed consent was obtained from all
participants. This study was approved by the Institutional Review Board of the collaborating
institutions.
SNP selection and genotyping
We selected three SNPs in CAT for genotyping (rs4756146, rs2284365, and rs480575). A
tagging strategy was employed to maximize our ability to capture genetic variation across
the CAT gene (gene and 1,000 bp upstream and downstream). Tag SNPs were selected
using the SNPinfo web server from the National Institute of Environmental Health Science
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[22] based on data from phase I and II of the International HapMap Project database [23].
Given the racial homogeneity of the LIBCSP population with DNA available for the
proposed analyses [24], the CEU population (30 Utah trios with ancestry from northern and
western Europe) was used as the reference panel for SNP selection. We imposed a minor
allele frequency (MAF) cutoff value of 10 % and r2 threshold minimum of 0.80 on SNP
selection procedures. From the 11 tag SNPs identified to capture the CAT region, three were
singleton or double bins, two had MAF <10 %, and one was previously genotyped in
LIBCSP. Of the remaining five tag SNPs, we selected three based on location, bin size, and
linkage disequilibrium with functional variants.
In addition to the newly genotyped CAT variants, we selected 10 functional polymorphisms
from nine genes in the oxidative stress pathway to assess gene*environment (G*E)
interactions with RPA: CAT (rs1001179), COMT (rs4680 and rs737865), GPX (rs1050450),
GSTA1 (rs3957356), GSTM1 (gene deletion), GSTP1 (rs1695), GSTT1 (gene deletion),
MnSOD (rs4880), and MPO (rs2333227). A single base pair change affecting polyphen
prediction (GPX), transcription factor binding prediction (CAT, COMT rs737865, MNSOD,
and GSTA1), miRNA binding (GPX), 3D conformation (COMT rs4680), or splicing
regulation (GPX, COMT rs4680, MPO, and GSTP1) were defined as potentially functional
SNPs. Similarly, base pair changes that were non-synonymous (GPX, COMT rs4680, MPO,
and GSTP1) or resulted in a stop codon were also classified as potentially functional. These
polymorphisms were identified through the breast cancer literature and the SNPinfo web
server [22]. The main effects of these associations with breast cancer risk have been
previously reported in the LIBCSP study population [11, 25–30]. However, interactions with
physical activity have not been considered. Previously published SNP-specific effects
among postmenopausal women for the genes of interest are provided to offer a full pathway
context for our findings on the effect of RPA and ROS-related polymorphisms.
A non-fasting 40 mL blood sample was obtained from participants at the time of interview
and shipped at room temperature, overnight, for processing. Genomic DNA was extracted
from mononuclear cells in whole blood separated by Ficoll (Sigma Chemical Co., St. Louis,
Missouri). Pelleted cells were frozen at −80 °C until DNA isolation by standard phenol, and
chloroform isoamyl alcohol extraction and RNase treatment were performed [21].
Genotyping of newly selected CAT SNPs was accomplished using Taqman assays (Applied
Biosystems, Foster City, CA) in 384-well plates. For the remaining SNPs, genotyping was
performed by BioServe Biotechnologies (Laurel, MD) using Sequenom’s high-throughput
matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, as described
previously [30]. Controls for genotype and two non-template controls were included on each
plate. Samples that were outside the variables defined by the controls were identified as non-
informative and retested. For quality control, 10 % of samples were distributed throughout
the DNA samples as blinded duplicates. Laboratory personnel were blinded to case–control
status, and all genotyping results were reviewed manually.
Recreational physical activity and covariate assessment
Exposure information was obtained from two sources: the interviewer-administered
structured questionnaire and laboratory analyses using blood samples to obtain genotypes
for CAT and oxidative stress genes. As part of the structured questionnaire, participants
were asked about their involvement in RPA using a modified instrument developed by
Bernstein and colleagues [31]. Women were asked about all activities in which they had
engaged for at least 1 h per week and 3 months or more in any year over the life course.
Women who reported never having participated in activity were classified as having no
RPA. Among ever RPA participators, information on the activity name, the ages the activity
was started and stopped, and the number of hours per week and months per year the activity
was performed was obtained. Activity data for ever participators were summed across all
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activities for each year of a woman’s life, providing a lifetime composite score of exercise
duration from menarche (left truncated) to reference date. We previously reported the main
effects of RPA during four etiologically relevant time periods (adolescent, reproductive,
postmenopausal, and lifetime RPA) [32]. For the present analyses, we assessed the
interaction between polymorphisms in oxidative stress genes and two time periods for which
the effects for breast cancer were strongest: postmenopausal and lifetime RPA. Given our
previous analysis showed no substantial differences by intensity [32], we report RPA using
average hours only.
During the interviewer-administered structured questionnaire, participants were additionally
queried about their demographic characteristics; reproductive, medical, and environmental
histories; cigarette smoking and alcohol use; use of exogenous hormones; energy intake; and
select anthropometric measurements. Among eligible cases, clinical data on the
characteristics of their breast cancer diagnosis, including hormone receptor (HR) status,
were obtained from medical records.
Statistical methods
We first conducted tests for Hardy–Weinberg equilibrium (HWE) using observed genotype
frequencies among Caucasian controls and X2 test with one degree of freedom [33].
Unconditional logistic regression [34] was used to estimate odds ratios (ORs) and 95 %
confidence intervals (CIs) for the independent effects of CAT SNPs, their interactions, and
the joint effect of oxidative stress variants and RPA. All CAT SNPs were initially evaluated
using a general genetic model, but due to sparse data among women with the homozygous
variant genotype, a dominant model (at least one variant allele vs. no variant alleles) was
used for the analyses of main effects and subsequent interactions.
We identified potential confounders based on the known epidemiology of breast cancer and
analysis of causal diagrams [35]. For CAT variants, potential confounders were first degree
family history of breast cancer (yes/no), race (categorical), and religion (categorical). As
reported in our recently published manuscript [32] that examines effects for RPA on breast
cancer incidence, we considered the following potential confounders: education
(categorical), family history of breast cancer (yes/no), history of benign breast disease (yes/
no), income (categorical), lactation history (ever/never), use of oral contraceptives (ever/
never), parity (categorical), and smoking history (never, current, former). Confounders were
included in the final model if their inclusion changed the exposure estimate by greater than
10 % [36]. None of the above covariates met our criterion (which is consistent with the lack
of confounding noted in our previous examination of the main effect of physical activity on
breast cancer risk [32]). Additionally, adjustment for body mass did not alter our estimate by
greater than 10 %. Final models were therefore adjusted only for 5-year age group.
The main effect of CAT variants on breast cancer risk was assessed among all women and
within strata of menopausal status when the Breslow–Day p for homogeneity was <0.10
[37]. The effect of each CAT variant was evaluated by HR status stratifying cases into two
groups using information on estrogen receptor (ER) and progesterone receptor (PR) status
[38]: women with tumors that showed any hormone responsiveness (ER+/PR+, ER+/ PR−,
and ER−/PR+) and women who showed none (ER−/PR−).
We evaluated potential G*E interactions (both additive and multiplicative) by using
indicator terms for those with the genotype only, exposure only, and both the genotype and
exposure of interest. For genotype, we assessed interactions using a dominant genetic model
and for RPA, we classified participants into three categories with cut points based on the
median value among controls: no RPA, low RPA (<control median), and high RPA
(≥control median). Departures from the multiplicative null were assessed using the
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likelihood ratio test, comparing a model with and without the interaction terms [37].
Departures from the additive null were estimated by the interaction contrast ratio (ICR). The
magnitude of the additive interaction effect was estimated based on the following formula:
ICR = OR11–OR01–OR10+1 and its respective confidence interval obtained by ICR ± 1.96
SE (ICR) [39]. If the relative risk, as approximated by the OR, for both genotype and
exposure differed significantly from the relative risk of either factor alone added together
minus 1, we concluded that there was evidence of additive interaction [40]. All analyses
were conducted using SAS 9.1 (Cary, NC).
Results
HWE
Among Caucasian controls, the MAF for CAT SNPs rs4756146 C-, rs2284365 C-, and
rs480575 G-alleles were 14, 25, and 31 %, respectively. Allele frequencies were comparable
with those of the CEU HapMap population (8, 20, and 30 %), although control genotype
distributions for rs4756146 (p = 0.02) and rs2284365 (p = 0.01) deviated significantly from
HWE. Call rates were >95 % for CAT SNPs and we observed good agreement in the
randomly selected duplicates included for quality control (n discordant for rs4756146 [n = 3,
8.6 %] and rs2284365 [n = 0, 0 %]) suggesting that deviation from HWE was not due to
genotyping error.
Main SNP effects
The genotype frequencies and age-adjusted associations with breast cancer risk for CAT
polymorphisms are reported in Table 1. We observed no substantial associations between
the CAT SNPs rs4756146, rs2284365, or rs480575 and breast cancer risk when genes were
examined individually. However, the Breslow–day test for homogeneity revealed
modification by menopausal status for rs4756146 (p = 0.0419): strongest effects were
observed among postmenopausal women; those with CT or CC genotypes had decreased
risk of breast cancer compared with women with TT genotypes (OR = 0.77; 95 % CI, 0.59–
0.99) (Table 2). We observed a non-significant increase in risk of breast cancer among
premenopausal women carrying at least one variant allele (OR = 1.27; 95 % CI, 0.88–1.85).
We also found some suggestion of difference in the effect of rs4756146 by HR status. There
was an 11 % risk reduction among pre- and postmenopausal HR positive cases combined
(OR = 0.89; 95 % CI, 0.69–1.15) and a 34 % risk reduction among HR negative cases (OR =
0.66; 95 % CI, 0.40–1.08) compared with all controls. There was no modification by family
history or religion for any SNP, and no heterogeneity by menopausal status or across tumor
types for CAT rs2284365 and CAT rs480575 (data not shown). Our results did not vary
upon restriction to Caucasian women.
SNP–SNP interactions
We assessed all potential multiplicative interactions between the three newly genotyped
CAT polymorphisms described above and a functional CAT polymorphism (rs1001179)
previously reported by Ahn and colleagues [11]. Of the six possible two-way combinations,
we found only one potential interaction between rs480575 and rs2284365 (p = 0.087),
although this interaction did not reach statistical significance (a priori α = 0.05). We
observed a significantly decreased risk of breast cancer among women who carried at least
one variant allele for CAT rs480575 and were homozygous for common alleles for CAT
rs2284365 (OR = 0.69; 95 % CI, 0.49–0.96).
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The OR (95 % CI) for breast cancer risk by genotype and RPA are shown in Table 3 along
with previously reported postmenopausal age-adjusted main effects for RPA and genetic
variants. While we observed similar GxE results for lifetime RPA among all women, the
effects were stronger once restricted to postmenopausal participants. This is likely due to the
strength of the main effect as we previously found stronger inverse associations for
postmenopausal RPA than lifetime RPA [32]. Models are therefore presented among
postmenopausal women, using reduced variables for RPA (none, <control median, ≥control
median) and a dominant genetic model.
The association between postmenopausal breast cancer risk and carrying at least one variant
CAT allele (rs1001179; CT and TT genotypes) was increased among women who had
engaged in >9.23 h/week of RPA from menopause to reference date (OR = 1.61; 95 % CI,
1.06–2.45; p for multiplicative interaction = 0.043). There was a modest risk reduction (OR
= 0.89; 95 % CI, 0.59–1.34) among women who were heterozygous or homozygous for the
variant allele and moderately active (0.01–9.23 h/week). Despite the significant interaction,
the estimate in the no activity group was 1.36 (95 % CI, 0.83–1.21). We observed a
significant 44 % risk reduction (OR = 0.56; 95 % CI, 0.38–0.84) among postmenopausal
women who engaged in low to moderate RPA with at least one G allele (AG and GG
combined) in GSTP1 Ile105Val compared with those with the AA genotype (p for
multiplicative interaction = 0.006). Among highly active women, there was little effect of
genotype on breast cancer risk (OR = 1.08; 95 % CI, 0.71–1.64). There was some suggestion
of an inverse association between the TC and CC genotypes of CAT SNP rs4756146 and
postmenopausal breast cancer risk among non-active women (OR = 0.57; 95 % CI, 0.33–
0.98), however, we observed no significant interaction on the multiplicative scale for this or
any of the remaining SNP–RPA combinations. Stratum specific effects of genotype were
also assessed using splines for RPA. These analyses revealed similar results as our
categorical classification of RPA (data not shown). Additionally, our models did not support
the presence of an additive interaction between any of the 13 polymorphisms and RPA (data
not shown).
Discussion
In this population-based study, women with at least one variant allele in CAT rs4756146 had
a 23 % reduced risk of postmenopausal breast cancer compared with women with the
common TT genotype. The association was not observed among premenopausal women, or
when both pre-and postmenopausal women were considered together. Examination of
potential interactions between CAT SNPs revealed a significantly decreased risk of breast
cancer among women who carried at least one variant allele for rs480575 and were
homozygous for common alleles for rs2284365, although test of formal interaction was not
significant. When we examined joint effects of polymorphisms in oxidative stress genes and
RPA from menopause to reference date in relation to postmenopausal breast cancer risk, we
found some evidence for modification of genotype effect by activity level. A non-
statistically significant positive association was observed among women with more than one
variant CAT allele (rs1001179). This association was stronger and statistically significant
among participants who were highly active. The inverse association between GSTP1
Ile105Val and breast cancer was more pronounced among women who were moderately
active. These findings could indicate that lower neutralization of ROS may augment breast
cancer risk among a background of high RPA, whereas higher enzymatic activity may result
in enhanced risk reduction among women who are moderately physically active. However,
given the lack of evidence across other oxidative stress markers these results require
additional confirmation.
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There are multiple reports of the association between the functional catalase-262 C/T
polymorphism and breast cancer incidence in the epidemiologic literature [11, 15, 16], but
no study to date has assessed the individual or combined effects of CAT tag SNPs
(rs4756146, rs2284365, rs480575) and breast cancer risk. We found that the association
among women carrying at least one variant allele in CAT SNP rs4756146 varied by
menopausal status. While the exact mechanisms need to be further investigated, it is possible
that postmenopausal women (with a lower estrogen milieu) may more greatly benefit from
ROS removal. Given the important role of CAT in neutralizing ROS [1], polymorphisms
resulting in reduced enzyme activity may alter an individual’s ability to counter lipid
peroxidation and DNA oxidation thereby influencing cancer risk. However, in light of the
marginally significant odds ratios and little evidence for association among the remaining
polymorphisms, these results may be due to chance.
Many [11, 15, 27, 30], but not all [29], studies which examined the association between
ROS-related exposures, genotype, and breast cancer risk have shown that both ROS-
generating (e.g., cigarette smoking and exogenous hormones) and ROS-opposing factors
(e.g., consumption of fruits and vegetables) may interact with endogenous sources of pro-
and antioxidants to modify the effects of oxidative stress-related genetic polymorphisms on
breast cancer risk. Given the more complex physiological effects of physical activity, any
interactions with SNPs in the oxidative stress pathway may be challenging to disentangle.
Physical activity is a known inducer of ROS [41–43] and has been associated with lipid
peroxidation among trained athletes [44–46]. The seemingly paradoxical inverse association
between physical activity and breast cancer risk may be explained, in part, by the long-term
effects of regular exercise. Some studies suggest that while exercise-induced ROS
production may be an immediate systemic response to physical activity, the lasting effect of
regular exercise training is adaptation of antioxidant capacity [47, 48]. Regular activity has
been shown to enhance antioxidant status at multiple levels in both animal models and clinic
studies [49–53] and may render cells more resistant to subsequent oxidative insult [5]
thereby neutralizing the potentially mutagenic effects of lipid peroxidation [49]. Changes in
antioxidant status are proposed to occur even with moderate activity, which parallels our
knowledge of the association between physical activity and breast cancer.
We previously reported a non-linear dose response association between RPA and breast
cancer risk among postmenopausal women in the LIBCSP [32]. While a significant 30 %
risk reduction was observed among women in the third quartile of activity (OR = 0.70; 95 %
CI, 0.52–0.95) women in the highest quartile experienced a modest 16 % risk reduction (OR
= 0.84, 95 % CI, 0.63–1.13). Our finding was contrary to many previous epidemiologic
studies, which report an inverse dose-response association between physical activity and
breast cancer risk [17]; however, the high levels of activity reported by women in the
LIBCSP permitted us to consider a wider range of effects than prior investigations. One
possible explanation for inconsistent findings among highly active women may be the
presence of modification by biologically relevant genotypes. While the effect estimates for
RPA in quartiles 3 and 4 were not substantially different one could posit that ROS induction
among women with very high activity levels could be amplified by reduced antioxidant
capacity in relevant genes such as CAT. Moreover, moderate levels of RPA may enhance
risk reduction among women who are carriers of alleles known to be related to higher
endogenous enzymatic activity such as the GSTP1 Ile105Val variant [54–56]. Although
there is a strong biologic rational for the role of exercise in oxidative stress, the lack of
modification across other genes may suggest that the observed results are due to chance and
should be interpreted with caution.
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The effects observed in this study may be due to biases arising from sample selection, errors
in recall, or mis-classification of genotype. In the LIBCSP, blood donation varied by both
age and race [21]. While genotype is likely associated with race, given the small number of
non-white women (6.6 % non-white) included in our study, racial variations in blood
donation is likely negligible. Moreover, analyses restricted to Caucasian women resulted in
little change to observed estimates. Inaccurate recall of exposure variables can similarly lead
to biased results and is common in case–control studies. However, it is unlikely that
misclassification of RPA is differential with respect to genotype. We therefore expect that
recall differences by disease status would not substantially bias our interaction parameter
estimates. Distributions of two CAT variants deviated significantly from HWE, which may
inflate Type I error [57]. We anticipate that factors other than genotyping error (e.g., natural
selection or non-random mating) may be responsible for the departure from HWE given the
comparable allele frequency to the CEU HapMap population, the use of the high-throughput
genotyping methods, as well as the high call and concordance rates. This study benefits from
the relatively large sample size, which increased power to detect modest associations,
perform subgroup analyses, and evaluate joint effects of genotype and RPA. However, even
very large studies assessing main effects of genetic variants can quickly become
underpowered when examining gene–environment interactions. Although the racial
homogeneity of the LIBCSP population enhances internal validity, it is likely to reduce the
generalizability of our study results. Despite potential racial variation in genotype frequency
and exposure prevalence, we believe that this study may provide clues about the underlying
biologic mechanisms of oxidative stress and RPA which are unlikely to vary by race.
In summary, variant alleles in rs4756146 appear to be associated with reduced breast cancer
risk among post-menopausal women. The statistical interaction, on a multiplicative scale,
between CAT, postmenopausal RPA, and breast cancer may support our biologically
plausible hypothesis that ROS-generating risk factors act in combination with reduced
antioxidant expression to increase the risk of breast cancer. Similarly, the observed
interaction between GSTP1 and RPA could suggest that ROS are best neutralized in
environments where there is amplified anti-oxidant capacity either via endogenous or
exogenous mechanisms. This study is, to our knowledge, the first to assess the interaction
between oxidative stress genotypes and exercise. Our findings may support the link between
physical activity, genetic polymorphisms in genes related to antioxidant capacity, and breast
cancer risk, but given the probability of chance findings, these hypotheses should be
explored in other studies with adequate power and equally detailed exposure assessment.
Although genotype is non-modifiable, it is encouraging to note that women who were
moderately physically active had enhanced risk reduction when they were carriers of alleles
related to higher enzymatic activity.
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Table 2
Age-adjusted odds ratios and 95 % confidence intervals for the association between catalase SNP rs4756146
and breast cancer risk by menopausal status
Gene (rs) Cases Controls OR (95 % CI)a
CAT (rs4756146) premenopausal
 TT 241 282 1.00 Reference
 CT 70 68 1.32 (0.89, 1.94)
 CC 6 6 0.88 (0.27, 2.85)
 CT and CC 76 74 1.27 (0.88, 1.85)
CAT (rs4756146) postmenopausal
 TT 514 491 1.00 Reference
 CT 127 152 0.81 (0.62, 1.06)
 CC 12 23 0.51 (0.25, 1.04)
 CT and CC 139 175 0.77 (0.59, 0.99)
The Long Island Breast Cancer Study Project (1996–1997)
a
Odds ratio (OR) and 95 % confidence interval (CI)
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